CDH11 and meningioma: In addition, examination of CDH11 expression based on tumor types (Fig. S1K) revealed high expression level of CDH11 in astrocytoma (n = 3, M.S. = 278), glioblastoma (n = 5, M.S. = 277), oligodendroglioma (n = 3, M.S. = 264), meningioma (n = 6, M.S. = 248), pheochromocytoma (n = 4, M.S. = 237) and mesothelioma (n = 2, M.S. = 235).